Andrews, G. Should depression be managed as a chronic
2001; 322: 419–21.
Frank, E, Judge, R. Treatment recommendations versus treatment
realities: recognizing the rift and understanding the
consequences. J Clin Psychiatry
2001; 62 (suppl 22):
Lingam, R, Scott, J. Treatment non-adherence in affective
disorders. Acta Psychiatr Scand
2002; 105: 164–72.
Levine, J, Schooler, NR. SAFTEE: a technique for the systematic assessment of
side effects in clinical trials. Psychopharmacol
1986; 22: 343–81.
Lingjaerde, O, Ahlfors, UG, Bech, P, Dencker, SJ, Elgen, K. The UKU side effect rating scale. A new
comprehensive rating scale for psychotropic drugs and a cross-sectional
study of side effects in neuroleptic-treated patients.
Acta Psychiatr Scand Suppl
Jordan, S, Knight, J, Pointon, D. Monitoring adverse drug reactions: scales, profiles,
and checklists. Int Nurs Rev
2004; 51: 208–21.
Lambert, TJ, Cock, N, Alcock, SJ, Kelly, DL, Conley, RR. Measurement of antipsychotic-induced side effects:
support for the validity of a self-report (LUNSERS) versus structured
interview (UKU) approach to measurement. Hum
2003; 18: 405–11.
Lindstrom, E, Lewander, T, Malm, U, Malt, UF, Lublin, H, Ahlfors, UG. Patient-rated versus clinician-rated side effects of
drug treatment in schizophrenia. Clinical validation of a self-rating
version of the UKU Side Effect Rating Scale
(UKU-SERS-Pat). Nord J Psychiatry
2001; 55 (suppl 44):
Uher, R, Maier, W, Hauser, J, Marušič, A, Schmael, C, Mors, O, et al. Differential efficacy of escitalopram and
nortriptyline on dimensional measures of depression.
Br J Psychiatry
2009; 194, 252–9.
World Health Organization. The ICD–10
Classification of Mental and Behavioural Disorders: Clinical Descriptions
and Diagnostic Guidelines. WHO,
American Psychiatric Association. Diagnostic and
Statistical Manual of Mental Disorder (4th edn) (DSM–IV).
Wing, JK, Sartorius, N, Ustin, TB. Diagnosis and Clinical Measurement in Psychiatry. A
Reference Manual for SCAN. World Health
Montgomery, SA, Åsberg, M. A new depression scale designed to be sensitive to
change. Br J Psychiatry
1979; 134: 382–9.
Demyttenaere, K, Albert, A, Mesters, P, Dewe, W, De, BK, Sangeleer, M. What happens with adverse events during 6 months of
treatment with selective serotonin reuptake inhibitors?
J Clin Psychiatry
2005; 66: 859–63.
De Lima, MS, Hotopf, M. Benefits and risks of pharmacotherapy for dysthymia:
a systematic appraisal of the evidence. Drug
Remick, RA. Anticholinergic side effects of tricyclic
antidepressants and their management. Prog
Neuropsychopharmacol Biol Psychiatry
1988; 12: 225–31.
Degner, D, Grohmann, R, Kropp, S, Ruther, E, Bender, S, Engel, RR, et al. Severe adverse drug reactions of
antidepressants: results of the German multicenter drug surveillance
program AMSP. Pharmacopsychiatry
2004; 37 (suppl 1):
Trindade, E, Menon, D, Topfer, LA, Coloma, C. Adverse effects associated with selective serotonin
reuptake inhibitors and tricyclic antidepressants: a
1998; 159: 1245–52.
Gutierrez-Alvarez, AM. Do your patients suffer from excessive
Acta Psychiatr Scand
2007; 115: 80–1.
Hamilton, M. A rating scale for depression.
J Neurol Neurosurg Psychiatry
Beck, AT, Ward, CH, Mendelson, M, Mock, J, Erbaugh, J. An inventory for measuring
depression. Arch Gen Psychiatry
1961; 4: 561–71.
Uher, R, Farmer, A, Maier, W, Rietschel, M, Hauser, J, Marusic, A, et al. Measuring depression: comparison and
integration of three scales in the GENDEP study.
Cohen, J. Weighted kappa: Nominal scale agreement with
provision for scaled disagreement or partial credit.
1968; 70: 213–20.
Fleiss, JL, Cohen, J. The equivalence of weighted kappa and the intraclass
correlation coefficient as measures of reliability.
Educ Psychol Measurement
1973; 33: 613–9.
Flora, DB, Curran, PJ. An empirical evaluation of alternative methods of
estimation for confirmatory factor analysis with ordinal
data. Psychological Methods
2004; 9: 466–91.
Muthen, LK, Muthen, BO. Mplus User's Guide: Statistical Analysis with Latent
Variables. Muthen & Muthen,
Mokken, RJ. A Theory and Procedure of Scale Analysis.
Kent, JT. Robust properties of likelihood ratio
Hosmer, DW, Lemeshow, S. Applied Survival Analysis: Regression Modelling of Time to
Event Data. John Wiley &
Streiner, DL. Being inconsistent about consistency. When
coefficient alpha does and doesn't matter. J Pers
2003; 80: 217–22.
Moller, HJ. Methodological aspects in the assessment of severity
of depression by the Hamilton Depression Scale.
Eur Arch Psychiatry Clin Neurosci
2001; 251 (suppl 2):
Tang, NK, Salkovskis, PM, Hodges, A, Wright, KJ, Hanna, M, Hester, J. Effects of mood on pain responses and pain
tolerance: an experimental study in chronic back pain
Klauenberg, S, Maier, C, Assion, HJ, Hoffmann, A, Krumova, EK, Magerl, W, et al. Depression and changed pain perception. Hints
for a central disinhibition mechanism.
2008; 140: 332–43.
Wilson, K, Mottram, P. A comparison of side effects of selective serotonin
reuptake inhibitors and tricyclic antidepressants in older depressed
patients: a meta-analysis. Int J Geriatr
2004; 19: 754–62.
Verhamme, KM, Sturkenboom, MC, Stricker, BH, Bosch, R. Drug-induced urinary retention: incidence,
management and prevention. Drug Saf
2008; 31: 373–88.
Demyttenaere, K, Huygens, R. Painful ejaculation and urinary hesitancy in
association with antidepressant therapy: relief with
tamsulosin. Eur Neuropsychopharmacol
2002; 12: 337–41.
Vinberg, M. Attention to side effects enhances medical
adherence. Acta Psychiatr Scand
2007; 115: 82.